Guardian Pharmacy Services, Inc.

Day range

$39.03 – $40.17

Open

$39.74

Prev close

$39.44

Volume

71.35K

Market cap

$2.5B

Shares out

49.8M

P/E

37.90

P/S

1.71

P/B

10.17

P/FCF

28.16

ROE

26.8%

ROA

14.9%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 23, 2026

• Executive officer departureJun 22, 2026

  Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026. Upon his retirement, Mr. Forbes has agreed to continue as an employee of the Company from July 1 through August 31, 2026 to assist with the transition of his duties.

• Credit facilityMay 28, 2026

  The Amendment amends the Loan Agreement to, among other things, (i) replace references to Guardian Pharmacy, LLC with the Company as borrower and make certain related modifications to reflect the borrower's status as a public company, (ii) extend the maturity date of the revolving loan commitments from April 23, 2027 to May 21, 2030, (iii) permit the Company to add incremental term loans and/or increase the revolving loan commitments thereunder in an aggregate amount not to exceed $40 million, which could result in total borrowing capacity of $80 million, (iv) increase the amounts available under certain baskets and thresholds in the Loan Agreement and (v) replace the consolidated leverage ratio covenant with a consolidated net leverage ratio covenant.

• Control dispositionMar 23, 2026

  As disclosed in the Prospectus Supplement, prior to the Offering, the Company qualified as a "controlled company" within the meaning of the listing standards of the New York Stock Exchange ("NYSE"), as a majority of the Company's voting power for the election of directors (the "Voting Power") was held by the Selling Stockholders pursuant to a stockholders' agreement. Upon the consummation of the Offering, the Selling Stockholders no longer hold a majority of the Voting Power and the Company ceased to qualify as a "controlled company."

• Investor presentationJan 13, 2026

  The Company has prepared a presentation concerning its business that it intends to use in connection with the Company's presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at approximately 4:30 p.m. Pacific Time and for meetings with investors, analysts, and other interested parties.

• Investor presentationSep 18, 2025

  Guardian Pharmacy Services, Inc. (the "Company") has prepared a presentation concerning its business that it intends to use in connection with meetings with investors, analysts, and other interested parties from time to time. A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Days to cover

3.1

Short interest

2.48M

Avg volume

810.88K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Stock Market Today: S&P 500, Dow Jones Futures Slip As Jobless Claims Fall To 205,000— Micron, FedEx, Constellation Energy In Focus (UPDATED)
  negativeBenzinga· Mar 19, 2026
• Guardian Pharmacy Services Breakout Raises Questions on Strength of Q3 Momentum
  positiveInvesting.com· Nov 13, 2025
• Why Guardian Pharmacy Services Stock Was on a Tear Tuesday
  positiveThe Motley Fool· Nov 11, 2025